Quercetin enhances VDR activity, leading to stimulation of its target gene expression in Caco-2 Cells

Journal of Nutritional Science and Vitaminology

Volumn 56, Issue 5, 2010, Pages 326-330

  Inoue, Jun ^a   Choi, Jung Min ^a   Yoshidomi, Takehiro ^a   Yashiro, Takuya ^a   Sato, Ryuichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Caco 2; Quercetin; TRVP6; VDR

Indexed keywords

DNA BINDING PROTEIN; LUCIFERASE; MESSENGER RNA; QUERCETIN; TRANSCRIPTION FACTOR GAL4; VANILLOID RECEPTOR 6; VITAMIN D RECEPTOR;

ARTICLE; CONTROLLED STUDY; FOOD COMPOSITION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIGAND BINDING; SCREENING;

CACO-2 CELLS; CALCIUM CHANNELS; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; LIGANDS; QUERCETIN; RECEPTORS, CALCITRIOL; TRANSCRIPTIONAL ACTIVATION; TRPV CATION CHANNELS;

EID: 78651482825     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.56.326     Document Type: Article

References (25)

1. Carlberg C, Bendik I, Wyss A, Meier E, Sturzenbecker LJ, Grippo JF, Hunziker W. 1993. Two nuclear signalling pathways for vitamin D. Nature 361: 657-660.
2. Featherstone M. 2002. Coactivators in transcription initiation: Here are your orders. Curr Opin Genet Dev 12: 149-155.
3. Chan HM, La Thangue NB. 2001. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci 114: 2363-2373.
4. Rachez C, Gamble M, Chang CP, Atkins GB, Lazar MA, Freedman LP. 2000. The DRIP complex and SRC-1/ p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes. Mol Cell Biol 20: 2718-2726.
5. Chen JD, Umesono K, Evans RM. 1996. SMRT isoforms mediate repression and antirepression of nuclear receptor heterodimers. Proc Natl Acad Sci USA 93: 7567-7571.
6. Polly P, Herdick M, Moehren U, Baniahmad A, Heinzel T, Carlberg C. 2000. VDR-Alien: A novel, DNA-selective vitamin D3 receptor-corepressor partnership. FASEB J 14: 1455-1463.
7. Bischoff SC. 2008. Quercetin: potentials in the prevention and therapy of disease. Curr Opin Clin Nutr Metab Care 6: 733-740.
8. Perez-Vizcaino F, Bishop-Bailley D, Lodi F, Duarte J, Cogolludo A, Moreno L, Bosca L, Mitchell JA, Warner TD. 2006. The flavonoid quercetin induces apoptosis and inhibits JNK activation in intimal vascular smooth muscle cells. Biochem Biophys Res Commun 346: 919-925.
9. de Whalley CV, Rankin SM, Hoult JR, Jessup W, Leake DS. 1990. Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem Pharmacol 39: 1743-1750.
10. Richter M, Ebermann R, Marian B. 1999. Quercetininduced apoptosis in colorectal tumor cells: possible role of EGF receptor signaling. Nutr Cancer 34: 88-99.
11. Kuo SM. 1996. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett 110: 41-48.
12. Gulati N, Laudet B, Zohrabian VM, Murali R, Jhanwar-Uniyal M. 2006. The antiproliferative effect of Quercetin in cancer cells is mediated via inhibition of the PI3KAkt/ PKB pathway. Anticancer Res 26: 1177-1181.
13. Rivera L, Morón R, Sánchez M, Zarzuelo A, Galisteo M. 2008. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity 16: 2081-2087.
14. Edwards RL, Lyon T, Litwin SE, Rabovsky A, Symons JD, Jalili T. 2007. Quercetin reduces blood pressure in hypertensive subjects. J Nutr 137: 2405-2411.
15. Duarte J, Pérez-Palencia R, Vargas F, Ocete MA, Pérez-Vizcaino F, Zarzuelo A, Tamargo J. 2001. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br J Pharmacol 133: 117-124.
16. Misawa K, Horiba T, Arimura N, Hirano Y, Inoue J, Emoto N, Shimano H, Shimizu M, Sato R. 2003. Sterol regulatory element-binding protein-2 interacts with hepatocyte nuclear factor-4 to enhance sterol isomerase gene expression in hepatocytes. J Biol Chem 278: 36176-36182.
17. Sato R, Miyamoto W, Inoue J, Terada T, Imanaka T, Maeda M. 1999. Sterol regulatory element-binding protein negatively regulates microsomal triglyceride transfer protein gene transcription. J Biol Chem 274: 24714-24720.
18. Meyer MB, Watanuki M, Kim S, Shevde NK, Pike JW. 2006. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25- dihydroxyvitamin D3 in intestinal cells. Mol Endocrinol 20: 1447-1461.
19. Yuan H, Young CY, Tian Y, Liu Z, Zhang M, Lou H. 2010. Suppression of the androgen receptor function by quercetin through protein-protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells. Mol Cell Biochem 339: 253-262.
20. Yuan H, Gong A, Young CY. 2005. Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells. Carcinogenesis 26: 793-801.
21. Hoenderop JG, Bindels RJ. 2008. Calciotropic and magnesiotropic TRP channels. Physiology 23: 32-40.
22. Cui M, Klopot A, Jiang Y, Fleet JC. 2009. The effect of differentiation on 1,25 dihydroxyvitamin D-mediated gene expression in the enterocyte-like cell line, Caco-2. J Cell Physiol 218: 113-121.
23. Terao J, Kawai Y, Murota K. 2008. Vegetable flavonoids and cardiovascular disease. Asia Pac J Clin Nutr 17 (Suppl 1): 291-293.
24. Nemeth K, Plumb GW, Berrin JG, Juge N, Jacob R, Naim HY, Williamson G, Swallow DM, Kroon PA. 2003. Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur J Nutr 1: 29-42.
25. van der Woude H, Gliszczynska-Swiglo A, Struijs K, Smeets A, Alink GM, Rietjens IM. 2003. Biphasic modulation of cell proliferation by quercetin at concentrations physiologically relevant in humans. Cancer Lett 200: 41-47.